Deutsche Bank Upgrades Teladoc on Valuation

Deutsche Bank upgraded Teladoc from Hold to Buy, setting a price target of $11. This target represents significant upside potential from the current trading price of around $5.30. The upgrade is based on a compelling valuation, with the stock trading at 4.2 times its 2026 EBITDA estimate. Deutsche Bank views Teladoc's strategy for BetterHelp, which involves transitioning to an insurance-covered business, as a more promising long-term growth model. This pivot addresses affordability, which Teladoc identified as a primary reason for customer churn at BetterHelp. Teladoc plans to have the infrastructure to contract with insurers in place by the end of 2024, with rollouts continuing through 2025. The upgrade also considers UnitedHealth Group's recent acquisition of Talkspace, a competitor of BetterHelp in the insured market. UHS is acquiring Talkspace for $5.25 per share, valuing the company at approximately $835 million. Talkspace's 2025 revenue was $229 million, with over 1.6 million patient sessions. Teladoc's Integrated Care segment is also growing, offsetting the shrinking BetterHelp segment. The company reported Q4 2025 earnings with an EPS of -$0.14, surpassing the forecast of -$0.18, and revenue of $642 million, exceeding the expected $635.31 million. BofA Securities also upgraded Teladoc, citing an improved margin outlook for BetterHelp.